ARB superiority over ACE inhibitors in Coronary Heart Disease: An Alternative Viewpoint.

A recent observational study published in Pharmacotherapy suggests that treatment with an angiotensin receptor blocker (ARB), compared to an angiotensin-converting enzyme (ACE) inhibitor, each combined with statin therapy, substantially reduces cardiovascular events and mortality in patients with newly-diagnosed coronary heart disease. This Alternative Viewpoint describes major biases introduced in the study design that likely contributed to this surprising finding This article is protected by copyright. All rights reserved.